Industry reports
Editor highlights

Biological Therapy Industry in Singapore: Market Research Reports, Statistics and Analysis

You might be interested in: cell therapy, stem cell, cell culture, more »

» View Public Reports

6 reports

Cell Therapy Market in Japan, India and Singapore

  • Industry report
  • January 2012
  • 5 pages

Company Report: Biological Therapy in Singapore and Australia for Year 2013

  • Company report
  • October 2013
  • 19 pages

... Had > $1bn in annual revenue worldwide and attracted >$900m in investment from private investors and public markets worldwide first advanced cell therapy approved in may 12 for gvhd page ...

Company Report: Biological Therapy in Singapore and Australia for Year 2013

  • Company report
  • October 2013
  • 19 pages
  • by Corporation

... Topical inflammatory skin conditions other applications pain, oncology other inflammatory conditions pain, oncology other inflammatory conditions secretions hiqcell leading autologous cell ...

Company Report: Biological Therapy in Singapore and Australia for Year 2013

  • Company report
  • October 2013
  • 19 pages
  • by Corporation

Company Report: Biological Therapy in Singapore and Australia for Year 2013

  • Company report
  • October 2013
  • 19 pages

... cell therapies - 3 product platforms based on proprietary adipose (fat) derived stem cell technologies generated breakthrough clinical data validating its therapies for osteoarthritis (oa ...

Investor presentation: Biological Therapy in The United States, Australia and Singapore for Year 2012

  • Company report
  • December 2012
  • 21 pages

... Half-year financial results leading the world in novel adult stem cell therapies cautionary note regarding forward-looking statements this presentation, including any comments ...

Search in Biological Therapy Industry

» Purchase Premium Reports (From $ 250 - $ 250)

2 reports
ES Cell International Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ES Cell International Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary ES Cell International Pte, Ltd. (ESI) is a regenerative medicine company, based in Singapore. The company develops human embryonic stem cell technologies for research and commercial applications. ...

Es Cell International Pte Ltd - Pharmaceuticals & Healt ...

May 2013 $ 250

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.